What ICER’s Analysis of Tardive Dyskinesia Treatments Doesn’t Explain
October 30, 2017
The Institute for Clinical and Economic Review recently evaluated treatments for tardive dyskinesia, a movement disorder related to the long-term use of antipsychotic medications to treat serious mental illness. Men and women with TD experience uncontrollable movements of their face, limbs or torso – along with intense social stigma.
ICER’s report says the treatments are not cost effective. But it leaves several key questions unanswered.
Tags: Cost Value, Neurological
Categorized in: Analysis